Funding for this research was provided by:
Received: 30 November 2022
Accepted: 30 April 2023
First Online: 25 May 2023
: Not applicable.
: EMD, CT, and BDG are employees of Pfizer and may hold company stock. MPES has received personal fees from GSK, Pfizer, AstraZeneca, and Sanofi Pasteur as a speaker at international meetings and as a member of advisory boards (unrelated to the submitted work). MPES has undertaken contract work for Pfizer.